Matsuoka Hirofumi, Nakashima Yuichi, Oshima Kazuhiro, Tanaka Masatoshi
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Ren Fail. 2007;29(7):797-803. doi: 10.1080/08860220701573467.
In the treatment of progressive reflux nephropathy (RN), the therapeutic benefit and prognosis of the renal function in RN patients appears to be influenced by the degree of renal functional reserve. We designed this study to determine the presence and characteristics of the renal functional reserve in RN patients.
In the 35 RN patients with renal scars (19 males; mean age 16.1 years), an exogenous renal clearance test was performed to measure the glomerular filtration rate (GFR) and the effective renal plasma flow (ERPF). In the second half of this test, the renal functional reserve was estimated by measuring the GFR and ERPF during low-dose dopamine infusion. These measurements were then compared with the glomerular size, which had been previously determined by a renal biopsy.
Among the patients with a normal glomerular size (-2SD to +2SD), the GFR markedly increased after low-dose dopamine infusion (from 112.15 +/- 52.51 to 182.07 +/- 69.95 mL/min, p < 0.0001), whereas an increase in ERPF was not significant. Among the patients with an enlarged glomerular size (+2SD to +4SD), the GFR and ERPF increased significantly over the baseline values (from 54.60 +/- 32.90 to 114.00 +/- 65.48 mL/min, p = 0.0076; from 281.01 +/- 152.54 to 622.43 +/- 392.73 mL/min, p = 0.0155, respectively). Among the patients with an extremely enlarged glomerular size (>+4SD), both the GFR and ERPF remained almost completely unchanged.
The renal functional reserve was present even among progressive RN patients with a glomerular size ranging between +2SD and +4SD.
在进行性反流性肾病(RN)的治疗中,RN患者肾功能的治疗益处和预后似乎受肾功能储备程度的影响。我们设计本研究以确定RN患者肾功能储备的存在情况及特征。
对35例有肾瘢痕的RN患者(19例男性;平均年龄16.1岁)进行外源性肾清除试验,以测量肾小球滤过率(GFR)和有效肾血浆流量(ERPF)。在该试验的后半部分,通过在低剂量多巴胺输注期间测量GFR和ERPF来评估肾功能储备。然后将这些测量结果与先前通过肾活检确定的肾小球大小进行比较。
在肾小球大小正常(-2SD至+2SD)的患者中,低剂量多巴胺输注后GFR显著增加(从112.15±52.51增至182.07±69.95 mL/min,p<0.0001),而ERPF的增加不显著。在肾小球大小增大(+2SD至+4SD)的患者中,GFR和ERPF均显著高于基线值(分别从54.60±32.90增至114.00±65.48 mL/min,p = 0.0076;从281.01±152.54增至622.43±392.73 mL/min,p = 0.0155)。在肾小球大小极度增大(>+4SD)的患者中,GFR和ERPF几乎完全未改变。
即使在肾小球大小介于+2SD和+4SD之间的进行性RN患者中也存在肾功能储备。